A heterogeneous network embedding framework for predicting similarity-based drug-target interactions

被引:62
作者
An, Qi [1 ]
Yu, Liang [1 ]
机构
[1] Xidian Univ, Coll Comp Sci & Technol, Xian, Peoples R China
基金
中国国家自然科学基金;
关键词
drug-target interaction; network embedding; heterogeneous network; machine learning; IDENTIFICATION; MODEL; MOLECULE; DATABASE;
D O I
10.1093/bib/bbab275
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Accurate prediction of drug-target interactions (DTIs) through biological data can reduce the time and economic cost of drug development. The prediction method of DTIs based on a similarity network is attracting increasing attention. Currently, many studies have focused on predicting DTIs. However, such approaches do not consider the features of drugs and targets in multiple networks or how to extract and merge them. In this study, we proposed a Network EmbeDding framework in mulTiPlex networks (NEDTP) to predict DTIs. NEDTP builds a similarity network of nodes based on 15 heterogeneous information networks. Next, we applied a random walk to extract the topology information of each node in the network and learn it as a low-dimensional vector. Finally, the Gradient Boosting Decision Tree model was constructed to complete the classification task. NEDTP achieved accurate results in DTI prediction, showing clear advantages over several state-of-the-art algorithms. The prediction of new DTIs was also verified from multiple perspectives. In addition, this study also proposes a reasonable model for the widespread negative sampling problem of DTI prediction, contributing new ideas to future research. Code and data are available at https://github.com/LiangYu-Xidian/NEDTP.
引用
收藏
页数:10
相关论文
共 55 条
  • [1] Drug-target interaction prediction through domain-tuned network-based inference
    Alaimo, Salvatore
    Pulvirenti, Alfredo
    Giugno, Rosalba
    Ferro, Alfredo
    [J]. BIOINFORMATICS, 2013, 29 (16) : 2004 - 2008
  • [2] The $2.6 Billion Pill - Methodologic and Policy Considerations
    Avorn, Jerry
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (20) : 1877 - 1879
  • [3] Supervised prediction of drug-target interactions using bipartite local models
    Bleakley, Kevin
    Yamanishi, Yoshihiro
    [J]. BIOINFORMATICS, 2009, 25 (18) : 2397 - 2403
  • [4] Structure-based maximal affinity model predicts small-molecule druggability
    Cheng, Alan C.
    Coleman, Ryan G.
    Smyth, Kathleen T.
    Cao, Qing
    Soulard, Patricia
    Caffrey, Daniel R.
    Salzberg, Anna C.
    Huang, Enoch S.
    [J]. NATURE BIOTECHNOLOGY, 2007, 25 (01) : 71 - 75
  • [5] Network-based prediction of drug combinations
    Cheng, Feixiong
    Kovacs, Istvan A.
    Barabasi, Albert-Laszlo
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [6] Comparative Toxicogenomics Database (CTD): update 2021
    Davis, Allan Peter
    Grondin, Cynthia J.
    Johnson, Robin J.
    Sciaky, Daniela
    Wiegers, Jolene
    Wiegers, Thomas C.
    Mattingly, Carolyn J.
    [J]. NUCLEIC ACIDS RESEARCH, 2021, 49 (D1) : D1138 - D1143
  • [7] Is there enough evidence with evolocumab and alirocumab (antibodies to proprotein convertase substilisin-kexin type, PCSK9) on cardiovascular outcomes to use them widely?
    Doggrell, Sheila Anne
    Lynch, Kaileen Anne
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (12) : 1671 - 1675
  • [8] Dogra S., 2016, SCI REP-UK, V6, P1
  • [9] Greedy function approximation: A gradient boosting machine
    Friedman, JH
    [J]. ANNALS OF STATISTICS, 2001, 29 (05) : 1189 - 1232
  • [10] ChEMBL: a large-scale bioactivity database for drug discovery
    Gaulton, Anna
    Bellis, Louisa J.
    Bento, A. Patricia
    Chambers, Jon
    Davies, Mark
    Hersey, Anne
    Light, Yvonne
    McGlinchey, Shaun
    Michalovich, David
    Al-Lazikani, Bissan
    Overington, John P.
    [J]. NUCLEIC ACIDS RESEARCH, 2012, 40 (D1) : D1100 - D1107